Hopp til hovedinnhold
Toggle navigation
Live markets
Search
Search
Search
Search
My profile
My Subscriptions
Watchlists
Quote alerts
Create account
Sign in
NB
FR
EN
PT
NL
NB
DE
IT
Hjem
Company Press Releases
Company press releases
Abonner
Filtre
Filtre
Oppdater
Nullstill
Icon After
Dato
Toggle Visibility
Alle
I dag
Denne uken
Denne måneden
Tilpasset datosøk
Fra
Til
Kategori
Toggle Visibility
Alliances and agreements
Annen informasjonspliktig regulatorisk informasjon
Change in Capital
Commercial operations
Commercial results
Corporate life
Dividend
Eks.dato
Endringer i rettighetene til aksjer / verdipapirer
Flagging
General meeting / Board Meeting
Halvårsrapporter og revisjonsberetninger / uttalelser om forenklet revisorkontroll
Ikke-informasjonspliktige pressemeldinger
Income
Innsideinformasjon
Joint venture
Journal / appointments
Kapital- og stemmerettsendringer
Legal
Meetings / events
Meldepliktig handel for primærinnsidere
Mergers, Acquiqitions, Transferts
New
New establishment
News contracts
Other financial transaction
Other subject
Polls / Surveys
Products and services
Prospekt / opptaksdokument
Rapportering om betaling til myndigheter (land-for-land rapportering)
Rating
Renteregulering
Sales
Share history
Share introduction and issues
Takeover bids
Trends / Analyses
Utsteders meldeplikt ved handel i egne aksjer
Valg av hjemstat
Årsrapporter og revisjonsberetninger
Leverandør
Toggle Visibility
ActusNewsWire
BusinessWire
EQS Group
Euronext
GlobeNewswire
Les Echos
Marketwire
Modular Finance
Oslo Børs Newspoint
PR Newswire
Viser 1 - 50 av 237 resultater
Tid
Selskap
Tittel
Sektor
Kategori
28 Jun 2024
07:00 CEST
BIOSENIC
BioSenic S.A. : Information relative au nombre total de droits de vote et d’actions
20103010 Biotechnology
Corporate life
28 Jun 2024
07:00 CEST
BIOSENIC
BioSenic S.A. : Information on the total number of voting rights and shares
20103010 Biotechnology
Corporate life
21 Jun 2024
18:00 CEST
BIOSENIC
BioSenic signs a new subscription agreement for a maximum of EUR 2.1M in convertible bonds
20103010 Biotechnology
Alliances and agreements
21 Jun 2024
18:00 CEST
BIOSENIC
BioSenic signe une nouvelle convention de souscription pour un maximum de 2,1 millions d'euros en obligations convertibles
20103010 Biotechnology
Alliances and agreements
14 Jun 2024
07:00 CEST
BIOSENIC
The Enterprise Court of Nivelles approves the BioSenic restructuring plan
20103010 Biotechnology
Legal
14 Jun 2024
07:00 CEST
BIOSENIC
Le Tribunal de l'entreprise de Nivelles homologue le plan de restructuration de BioSenic
20103010 Biotechnology
Legal
12 Jun 2024
07:00 CEST
BIOSENIC
BioSenic to host Annual General Meeting on July 12, 2024
20103010 Biotechnology
General meeting / Board Meeting
12 Jun 2024
07:00 CEST
BIOSENIC
BioSenic tiendra son Assemblée Générale Ordinaire le 12 juillet 2024
20103010 Biotechnology
General meeting / Board Meeting
06 Jun 2024
21:05 CEST
BIOSENIC
BioSenic announces 2023 full year results
20103010 Biotechnology
Legal
06 Jun 2024
21:05 CEST
BIOSENIC
BioSenic publie ses résultats annuels 2023
20103010 Biotechnology
Legal
31 May 2024
07:00 CEST
BIOSENIC
BioSenic S.A. : Information relative au nombre total de droits de vote et d’actions
20103010 Biotechnology
Corporate life
31 May 2024
07:00 CEST
BIOSENIC
BioSenic S.A. : Information on the total number of voting rights and shares
20103010 Biotechnology
Corporate life
27 May 2024
17:00 CEST
BIOSENIC
BioSenic S.A. : Vote positif de la majorité des créanciers en faveur du plan global de restructuration de BioSenic couvrant les années 2024-2032, au Tribunal d'Entreprise de Nivelles
20103010 Biotechnology
Legal
27 May 2024
17:00 CEST
BIOSENIC
BioSenic S.A. : Positive vote of the majority of creditors in favor of the global restructuring plan of BioSenic covering the years 2024-2032, at the Enterprise Court of Nivelles
20103010 Biotechnology
Legal
24 May 2024
17:00 CEST
BIOSENIC
BioSenic fait le point sur ses activités du premier trimestre 2024
20103010 Biotechnology
Corporate life
24 May 2024
17:00 CEST
BIOSENIC
BioSenic provides First Quarter 2024 Business Update
20103010 Biotechnology
Corporate life
30 Apr 2024
07:00 CEST
BIOSENIC
BioSenic S.A. : Information relative au nombre total de droits de vote et d’actions
20103010 Biotechnology
Change in Capital
30 Apr 2024
07:00 CEST
BIOSENIC
BioSenic S.A. : Information on the total number of voting rights and shares
20103010 Biotechnology
Change in Capital
26 Apr 2024
17:30 CEST
BIOSENIC
BioSenic publishes on its website the restructuring plan submitted to the Enterprise Court of Nivelles
20103010 Biotechnology
Legal
26 Apr 2024
17:30 CEST
BIOSENIC
BioSenic publie sur son site web le plan de restructuration soumis au tribunal des entreprises de Nivelles
20103010 Biotechnology
Legal
24 Apr 2024
07:00 CEST
BIOSENIC
BioSenic postpones its annual general meeting of the shareholders and provides temporary non-audited financial figures for 2023
20103010 Biotechnology
Other subject
24 Apr 2024
07:00 CEST
BIOSENIC
BioSenic reporte son assemblée générale annuelle des actionnaires et fournit des chiffres financiers temporaires non-audités pour 2023
20103010 Biotechnology
Other subject
18 Apr 2024
07:00 CEST
BIOSENIC
BioSenic S.A. : Transparency notifications received from François Rieger
20103010 Biotechnology
Legal
18 Apr 2024
07:00 CEST
BIOSENIC
BioSenic S.A. : Notifications de transparence reçues de la part de François Rieger
20103010 Biotechnology
Legal
12 Apr 2024
12:00 CEST
BIOSENIC
BioSenic provides further information on its restructuring plan
20103010 Biotechnology
Legal
12 Apr 2024
12:00 CEST
BIOSENIC
BioSenic fournit des informations complémentaires sur son plan de restructuration
20103010 Biotechnology
Legal
11 Apr 2024
14:00 CEST
BIOSENIC
BioSenic et son praticien de la restructuration (Me Yves Brulard) soumettent un plan de restructuration global engageant les années 2024-2030 au Tribunal de l’entreprise de Nivelles
20103010 Biotechnology
Legal
11 Apr 2024
14:00 CEST
BIOSENIC
BioSenic and its restructuring practitioner (Me Yves Brulard) submit a global restructuring plan covering the years 2024-2030 to the Enterprise Court of Nivelles
20103010 Biotechnology
Legal
29 Mar 2024
07:00 CET
BIOSENIC
BioSenic S.A. : Information relative au nombre total de droits de vote et d’actions
20103010 Biotechnology
Legal
29 Mar 2024
07:00 CET
BIOSENIC
BioSenic S.A. : Information on the total number of voting rights and shares
20103010 Biotechnology
Legal
20 Mar 2024
07:00 CET
BIOSENIC
BioSenic présente des données précliniques concluantes sur son médicament ATO pour le contrôle des principaux symptômes au Congrès mondial 2024 sur la sclérose systémique
20103010 Biotechnology
Corporate life
20 Mar 2024
07:00 CET
BIOSENIC
BioSenic presents successful preclinical data on its ATO medication for controlling key symptoms at the 2024 Systemic Sclerosis World Congress
20103010 Biotechnology
Corporate life
12 Mar 2024
07:00 CET
BIOSENIC
BioSenic publie les détails de la stratégie d'administration optimisée pour OATO dans le traitement de la maladie chronique du greffon contre l'hôte en amont du prochain essai de phase 3
20103010 Biotechnology
Corporate life
12 Mar 2024
07:00 CET
BIOSENIC
BioSenic releases details of optimized administration approach ahead of planned Phase 3 trial of OATO for chronic graft-versus-host disease
20103010 Biotechnology
Corporate life
29 Feb 2024
07:00 CET
BIOSENIC
BioSenic S.A. : Information on the total number of voting rights and shares
20103010 Biotechnology
Legal
29 Feb 2024
07:00 CET
BIOSENIC
BioSenic S.A. : Information relative au nombre total de droits de vote et d’actions
20103010 Biotechnology
Legal
02 Feb 2024
17:30 CET
BIOSENIC
BioSenic raises €500,000 in private placement of new shares with established new investors
20103010 Biotechnology
Share introduction and issues
02 Feb 2024
17:30 CET
BIOSENIC
BioSenic lève 500 000 euros dans le cadre d'un placement privé d'actions nouvelles auprès de nouveaux investisseurs établis
20103010 Biotechnology
Share introduction and issues
31 Jan 2024
10:30 CET
BIOSENIC
BioSenic provides support to forthcoming European conference on graft-versus-host disease
20103010 Biotechnology
Corporate life
31 Jan 2024
10:30 CET
BIOSENIC
BioSenic soutient la prochaine conférence européenne sur la maladie du greffon contre l'hôte
20103010 Biotechnology
Corporate life
30 Jan 2024
07:00 CET
BIOSENIC
BioSenic patent granted in Canada for broader protection of ATO therapeutic platform
20103010 Biotechnology
Corporate life
30 Jan 2024
07:00 CET
BIOSENIC
Le brevet de BioSenic est accordé au Canada pour une protection plus large de sa plate-forme thérapeutique ATO
20103010 Biotechnology
Corporate life
25 Jan 2024
07:00 CET
BIOSENIC
BioSenic présente de nouvelles données de phase 3 sur JTA-004 pour le traitement de la douleur arthrosique sévère lors du congrès mondial de l'OARSI 2024
20103010 Biotechnology
Corporate life
25 Jan 2024
07:00 CET
BIOSENIC
BioSenic presents new Phase 3 data on JTA-004 to treat severe osteoarthritis pain at the 2024 OARSI World Congress
20103010 Biotechnology
Corporate life
23 Jan 2024
07:00 CET
BIOSENIC
BioSenic dépose une demande de protection supplémentaire par brevet, suite à de nouvelles preuves cliniques de l'efficacité de JTA-004 dans le traitement de l'arthrose
20103010 Biotechnology
Corporate life
23 Jan 2024
07:00 CET
BIOSENIC
BioSenic files for additional patent protection following new clinical evidence of efficacy for JTA-004 in osteoarthritis
20103010 Biotechnology
Corporate life
15 Jan 2024
07:00 CET
BIOSENIC
BioSenic S.A. : Notifications de transparence reçues de la part de François Rieger
20103010 Biotechnology
Other subject
15 Jan 2024
07:00 CET
BIOSENIC
COMMUNIQUE DE PRESSE – INFORMATION PRIVILIGIEE
20103010 Biotechnology
Alliances and agreements
15 Jan 2024
07:00 CET
BIOSENIC
BioSenic S.A. : Transparency notifications received from François Rieger
20103010 Biotechnology
Other subject
15 Jan 2024
07:00 CET
BIOSENIC
BioSenic reaches agreement on a binding term sheet with Phebra PTY Ltd. with respect to the development of the first oral formulation of arsenic troxide for cGvHD treatment
20103010 Biotechnology
Alliances and agreements
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Sider
1
2
3
›
››
»
Last »
Company press releases subscription
×
To subscribe to Press releases from this issuer, visit the Subscription to Company news section in
Hjem
Markeder
Amsterdam
Cash Products
Aksjer
AEX index Stocks
AEX ESG Stocks
Indekser
Fond
Obligasjoner
ETF-er
Strukturerte produkter
Derivater
Indeksopsjoner
Indeksfutures
Aksjeopsjoner
Utbyttederivater
Aksjefutures
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Brussel
Cash products
Aksjer
Euronext regulated
Euronext Growth
Euronext Access
Expert Market
BEL 20 Stocks
Indekser
Obligasjoner
ETF-er
Strukturerte produkter
Derivater
Indeksfutures
Aksjeopsjoner
Aksjefutures
Utbyttederivater
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Expert Market
Dublin
Stocks
Euronext regulated
Euronext Growth
ISEQ 20 Stocks
Indices
Funds
Bonds
Irish Government Bonds
DOL
Lisboa
Cash Products
Aksjer
Euronext regulated
Euronext Access
PSI Stocks
Indekser
Obligasjoner
Derivater
Indeksfutures
Aksjefutures
Utbyttederivater
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Milan
Cash Products
Stocks
Euronext Milan
Euronext Growth Milan
Euronext Star Milan
Euronext Global Equity Market
EuroTLX
Trading After Hours
MIB ESG Stocks
Bonds
MOT
Euronext Access Milan
EuroTLX
Structured Products
SeDeX
EuroTLX
ETFs
Funds
Derivative products
All derivatives
Index futures
Index options
Stock options
Stock futures
Dividend derivatives
Quote Vendor Codes
IPOs
Oslo
Aksjer, renter, indekser
Aksjer
Oslo Børs
Euronext Growth
Euronext Expand
Top performers
OBX aksjer
OBX ESG aksjer
OSEBX aksjer
OSEFX Aksjer
Seafood Aksjer
Shipping Aksjer
Aksjeindekser
Obligasjoner
Oslo Børs
Nordic Alternative Bond Market
Obligasjonsindekser
ETFer
Fond
Derivater
Derivative products
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Finanskalender
Primærinnsidere
Paris
Cash Products
Aksjer
Euronext regulated
Euronext Growth
Euronext Access
CAC 40 Stocks
CAC 40 ESG Stocks
Indekser
Obligasjoner
ETF-er
Strukturerte produkter
Derivater
Indeksfutures
Indeksopsjoner
Aksjeopsjoner
Aksjefutures
Utbyttederivater
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Aksjer
All Markets directories
All Markets
Euronext regulated
Euronext Growth
Euronext Access
Euronext Expand
Euronext Global Equity Market
EuroTLX
Trading After Hours
Selskapsmeldinger
Latest
Archive
Nye aksjenoteringer
Alle aksjenoteringer
Euronext Growth advisors
Euronext Tech Leaders
Family business
Indekser
Directory
Grønne indekser
Indices documents
Indices news
Indekser høringer
Kontakter Euronext-indekser
ETF-er
Directory
Grønne ETF-er
Fond
Directory
ESG Funds
Oslo Mutual Funds
Obligasjoner
Grønne obligasjoner
1.5° Bonds
All Markets directories
All Markets
Amsterdam
Brussels
Dublin
Lisbon
Oslo
Milan
Paris
Strukturerte produkter
Directory / search
Bid-Only trading status
Trading Turbos in the Netherlands
Derivater
Indeksfutures
Indeksopsjoner
Aksjeopsjoner
Aksjefutures
Utbyttederivater
ETF opsjoner
Kontraktsspesifikasjoner
Tick sizes
Rapportering av handler
Leverandørkoder markedsdata
Råvarer
Quotes
Quotes snapshot
Milling Wheat futures
Rapeseed futures
Corn futures
European Durum Wheat Futures
Milling Wheat options
Rapeseed options
Corn options
Bortfallskalendre
Bortfall
Wholesale Trading
Commitments of Traders (CoT) report
Kontraktsspesifikasjoner
Leverandørkoder markedsdata
Knowledge Centre
Bid & Ask
Options Investing E-learning
Contract Specifications
Position Management
Intrinsic Value
Premium & Valuation
Moneyness
Positions
Euronext News
Ressurser
Statistikk & rapporter
Quality of execution
Åpningstider
Kontraktsspesifikasjoner
Leverandørkoder markedsdata
Key Information Document
Class level
Product group level
Notices / Corporate actions
Cash Notices / Corporate actions
Derivatives corporate actions
All Corporate Actions
Latest
Unusual Contract Sizes, Dividends
Corporate Action Services
Corporate Action Policies
Derivatives notices
Markedshendelser
Suspenderte instrumenter
Stressed Market Conditions
Brudd på Double Cap limits
Ekstraordinære markedsforhold
Diverse meldinger
Market status
Medlemsliste
Issuers compliance
Hvor du finner hva